BIO - Bio-Rad Laboratories, Inc.

NYSE - NYSE Verzögerter Preis. Währung in USD

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000

BrancheMedical Devices

Leitende Angestellte

Mr. Norman D. SchwartzChairman, CEO & Pres2,13M15,23M1950
Mr. Ilan DaskalExec. VP & CFO952,43kN/A1966
Dr. Andrew J. Last Ph.D.Exec. VP & COO1,12MN/A1960
Dr. Simon MayExec. VP & Pres of the Life Science Group787,76kN/AN/A
Ms. Dara Grantham WrightExec. VP & Pres of Clinical Diagnostics Group849,53kN/A1976
Mr. Ajit RamalingamSr. VP & Chief Accounting OfficerN/AN/A1973
Mr. Yong ChungVP of Investor RelationsN/AN/AN/A
Mr. Timothy S. ErnstExec. VP, Gen. Counsel & Sec.N/AN/A1960
Colleen CoreySr. VP of Global HRN/AN/AN/A
Mr. Michael CrowleyExec. VP of Global Commercial OperationsN/AN/A1962
Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.


Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Corporate Governance

Bio-Rad Laboratories, Inc.s ISS Governance QualityScore, Stand 1. Mai 2023, lautet 10. Die grundlegenden Scores sind Audit: 10, Vorstand: 10, Shareholderrechte: 10, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.